All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
9 METERS BIOPHARMA, INC.: Last Reported 3/31/2020

Business Address

8480 HONEYCUTT ROAD
SUITE 120
RALEIGH, NC US 27615

Mailing Address

8480 HONEYCUTT ROAD
SUITE 120
RALEIGH, NC US 27615
Phone Number: 919-275-1933 / State Incorporated: DE / Fiscal Year End 12/31

Balance Sheet

Date 3/31/2020 12/31/2019 3/31/2019 12/31/2018
Cash and Cash Equivalents $2,667,743.00 $4,592,932.00 -- --
Accounts Receivable Net Current -- -- -- --
Inventory -- -- -- --
Prepaid Expenses and Other Current Assets $488,211.00 $555,052.00 -- --
Total Current Assets $3,230,954.00 $5,222,984.00 -- --
Property Plant and Equipement $20,138.00 $25,422.00 -- --
Intangible Assets Net -- -- -- --
Goodwill -- -- -- --
Other Assets $5,580.00 $5,580.00 -- --
Total Assets $3,285,649.00 $5,296,816.00 -- --
Accounts Payable $5,075,478.00 $3,890,094.00 -- --
Accrued Liabilities $4,847,823.00 $4,747,751.00 -- --
Total Current Liabilities -- -- -- --
Long Term Debt -- -- -- --
Additional Paid-in Capital -- -- -- --
Accumulated Other Comprehensive Loss -- -- -- --
Accumulated Deficit $-74,167,779.00 $-70,564,778.00 -- --
Total Stockholders' Equity $-12,550,176.00 $-9,614,014.00 $1,617,607.00 $-3,659,064.00
Controlling Interest in Subsidiaries -- -- -- --
Total Liabilities and Equity $3,285,649.00 $5,296,816.00 -- --

Statement of Operations

Date 3/31/2020 12/31/2019 3/31/2019 12/31/2018
Total Revenues -- -- -- --
Cost of Revenues -- -- -- --
Gross Profit -- -- -- --
Research and Development $2,598,985.00 -- $1,198,315.00 --
Selling, General, and Administrative -- -- -- --
Total Operating Expenses $4,959,631.00 -- $4,312,810.00 --
Loss from Operations $4,959,631.00 -- $4,312,810.00 --
Loss Before Income Taxes $-3,603,001.00 -- $-4,434,765.00 --
Earnings Per Share Basic -- -- -- --
Weighted Average Shares Basic -- -- -- --
Earnings Per Share Diluted -- -- -- --
Weighted Average Shares Diluted -- -- -- --
Common Stock Shares Authorized 350,000,000 350,000,000 -- --
Common Stock Shares Outstanding 41,324,976 39,477,667 -- --
Copyright 2020 PursePoor.com